Frankfurt, Hesse, Germany
• Senior executive experience as board member, profit center head, commercial head, strategy & marketing head • Management consultant & advisor to private equity, global consultancy firms, pharma & healthcare companies. Focus areas: M&A, strategy formulation & implementation, new market development, portfolio management, business planning & launches • Executive management experience in leading organizations in pharmaceuticals & biologicals: oncology, biosimilars, critical care, anti-infectives, anaesthesia & pain management. Also experienced in medical devices, herbal healthcare products, and active pharma ingredients • Lead global pharma businesses with focus on Europe, China & rest of Asia Pacific, and USA. Also experienced in Russia & CIS, South America and Middle East • Successfully developed business for key markets, established offices and businesses in various countries, formulated and implemented business strategies to attain market leadership position • Successfully setup global and country teams to achieve business targets and to develop talent for future senior roles. Team oriented leader with balance focus on strategy & execution • Product portfolio for key therapy areas successfully planned and managed for global markets. Multiple major launches planned and managed to achieve business growth targets • Many key licensing and acquisition deals successfully completed, including negotiations, agreements, integration, both for small molecules as well as for biologicals
Executive board position to provide guidance on operational excellence, business planning, and strategic business growth
Board position to provide guidance on strategic business growth and achievement of short & long term goals
Oct 2017-Present: Member of Board of Directors Oct 2017-Present: CEO & Managing Partner CSA Healthcare is a management consultancy in pharma, life-sciences & med-tech space: • Business & Market Entry Strategy: Asia, China, Europe, USA, Oncology, Pain Management, Anaesthesia, Anti-infectives, Critical Care • Portfolio Strategy: Biosimilars, Peptides, Drug Device combinations, Exclusivities, Launches • Acquisitions: Business Due Diligence, Business Planning, Negotiations, Integration, Interim Mgt • Licensing: In & Out-licensing with focus on differentiated products & NCEs Key interim management roles: (1) Feb-Apr 2020: Archis Pharma Europe, President-Europe (interim management role) (2) Nov 2017-Jun 2018, AMCo (Germany) GmbH, Hamburg (part of Advanz Pharma (previously called Concordia), UK): Vice President-Global Portfolio Management (interim management role) Key Projects: (1) Oct 2018-Apr 2025: Ardian, Italy: "Acquisition of a specialty pharma company in Europe with differentiated products" (Jul 2019-Nov 2024: Sintetica SA, Member of Board of Directors) (2) July 2020-Dec 2021: "Acquisition of an Asian country business of a top 5 global Pharma & Healthcare company headquartered in Europe" (3) Feb-Apr 2020: "European business planning and distribution setup for a US specialty Pharma company" (4) Oct-Nov 2018, top 5 global management consultancy company, USA: "Speciality Injectables: best practices & commercial strategy"
July 2019-Nov 2024: Non-executive board position to provide guidance on strategic business growth and achievement of short & long term goals 2023-Apr 2025: Additional role of CCO to identify & implement key commercial strategies, lead the commercial team of the company and to manage profitable business growth
Board member of PharmSky Research, a company focused on "transforming discoveries into market ready products" and an end-to-end Contract Research and Development provider.